The FY2024 (Dec) proxy of Amgen names 14 peer companies for pay. Among Amgen and these peers, CEO pay was 3rd highest of 10 and total shareholder return was 6th highest of 10.
3rd highest of 10in Amgen and its pay peers, FY2024 (Dec) by CEO pay:
$6.8M$29.2M
6th highest of 10in Amgen and its pay peers, FY2024 (Dec) by total shareholder return:
$52$627
Pay peer group, FY2024 (Dec) proxy
| Eli Lilly & Co | ||
| Pfizer | ||
| Johnson & Johnson | ||
| Biogen | ||
| Gilead Sciences | ||
| Merck & Co. | ||
| Bristol Myers Squibb | ||
| AbbVie | ||
| Regeneron Pharmaceuticals | ||
| AstraZeneca plc | Not disclosed | Not disclosed |
| GlaxoSmithKline plc | Not disclosed | Not disclosed |
| Novartis AG | Not disclosed | Not disclosed |
| Roche Holding AG | Not disclosed | Not disclosed |
| Sanofi S.A. | Not disclosed | Not disclosed |
14 companies
Changes by year
FY2012 (Dec) proxy
- AddedAllergan, Inc.pay peer group
- AddedCelgene Corporationpay peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.